The Global Rett Syndrome Market is navigating a historic era of medical discovery. For decades, treatment was limited to palliative care, but with the 2023 FDA approval of the first disease-modifying therapy and a surge in gene-editing research, the market is expanding at an astronomical rate. https://www.databridgemarketresearch.com/